products through independent pharmacies, totaling approximately Baht 22.63 million which mounted year-on-year by Baht 19 .4 4 million ( the employment of Zuellig Pharma Ltd. took effect as from September 1
shareholder. This accounted 75.35 % in the third quarter of 2017. The company has not received a written valuation by an independent evaluation. So it is not yet recorded profit from changes to the investment
independent pharmacy channel, totaling approximately 4.99 million baht which increased by 2.24 million baht year-on-year due to increased sales. Some expenses have dropped i. e. sales promotion expenses, booth
Deduct Minority interest - - Net tangible assets (NTA) 604.68 (0.22) Plus Capital increase from ex-shareholder :At-Ze prior to share sale and purchase date* - 30.00 Net tangible assets (NTA)-adjusted
Intangible assets deduct 11.53 0.54 Deduct Total liabilities 315.37 157.34 Deduct Minority interest - - Net tangible assets (NTA) 604.68 (0.22) Plus Capital increase from ex-shareholder :At-Ze prior to share
29, 2004 (as amended) (the “Acquisition or Disposition Notification”). Details of the calculation are summarized below: 4.1 Comparison of Net Tangible Assets Size of Transaction = Net tangible assets
of Assets. From calculation the transaction found that size of transaction according to Net Tangible Assets Basis is highest equivalent to 15.89%, which the scope of transaction type 2. The Company
is equivalent to 0.30% of Company’s Net Tangible Asset (NTA) of THB 2,976.34 million (as of 31 December 2017), which is higher than 0.03% but less than 3% of the Company’s NTA. Hence the Company shall